Drugs / Aescuven
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06329167 Comparator | Mar 2024 → Jul 2025 | lymphedema | The First Hospital of Jilin University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aescuven | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06329167 ↗ |
| Route | Oral | “Aescuven Forte oral tablet 150mg (2 capsules/time, 2 times daily) and gradient compression stockings.” NCT06329167 ↗ |